HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) - ANVISA Registration 10338930121

Access comprehensive regulatory information for HERPES VIRUS (HHV 4) - EPSTEIN-BARR VIRUS (EBV) in Brazil's medical device market through Pure Global AI's free database. This Risk Class IV medical device is registered under ANVISA number 10338930121 and manufactured by manufacturer not specified. The registration is held by EUROIMMUN BRASIL MEDICINA DIAGNOSTICA LTDA with validity until Jun 02, 2035.

This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 similar products found using AI-powered semantic search, 5 companies making the same product including ABBOTT GMBH, SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD., and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
100,000+ Devices
5 Similar Products
5 Competitors
10338930121
2 Related Devices
Registration Details
ANVISA Registration Number: 10338930121
Janaina dos Santos de Miranda

Janaina dos Santos de Miranda

🇧🇷 Brazil Regulatory Expert

Need help with your Brazil registration?

Contact Pure Global Brazil Team
Free consultation

Related Devices (2)

Registration Details

10338930121

25351377321201430

93741726000166

Company Information

Dates and Status

Oct 13, 2014

02/06/2035

09/18/2025 19:00:01

Registration Details

10338930121

25351377321201430

93741726000166

Company Information

Germany
PT: ALEMANHA

Dates and Status

Oct 13, 2014

02/06/2035

09/18/2025 19:00:01